Home LiteratureArticle Details
PMID: 2523952 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization.

The Journal of experimental medicine ·Vol. 169 ·No. 5 ·1989-05-01 ·Pages 1565-81

Cooper CL, Mueller C, Sinchaisri TA, Pirmez C, Chan J, Kaplan G, Young SM, Weissman IL, Bloom BR, Rea TH, Modlin RL

Abstract

Analysis of tissue lesions of the major reactional states of leprosy was undertaken to study the immune mechanisms underlying regulation of cell-mediated immunity and delayed-type hypersensitivity (DTH) in man. In situ hybridization hybridization of reversal reaction biopsy specimens for INF-gamma mRNA expression revealed a 10-fold increase in specific mRNA-containing cells over that observed in unresponsive lepromatous patients. Expression of huHF serine esterase, a marker for T cytotoxic cells, were fourfold increased in reversal reaction and tuberculoid lesions above that detected in unresponsive lepromatous individuals. Immunohistology of reversal reactions confirmed a selective increase of Th and T cytotoxic cells in the cellular immune response. Of interest, the microanatomic location of these serine esterase mRNA-containing cells was identical to the distribution of CD4+ cells. Analysis of erythema nodosum leprosum (ENL) lesions revealed differences in the underlying immune processes in comparison with reversal reaction lesions. Although phenotypic Th cells predominated in ENL lesions, IFN-gamma and serine esterase gene expression were markedly reduced. We suggest that reversal reactions represent a hyperimmune DTH response characterized by a selective increase of CD4+ IFN-gamma producing cells and T cytotoxic cells, which result in the clearing of bacilli and concomitant tissue damage. In contrast, ENL reactions may be viewed as a transient diminution of Ts cells and activity leading to a partial and transient augmentation in cell-mediated immunity, perhaps sufficient to result in antibody and immune complex formation, but insufficient to clear bacilli from lesions.

MeSH Terms
Esterases/genetics Gene Expression Regulation Humans Hypersensitivity, Delayed Immunohistochemistry Interferon-gamma/genetics Leprosy/immunology,pathology Nucleic Acid Hybridization RNA, Messenger/analysis T-Lymphocytes/immunology T-Lymphocytes, Helper-Inducer/immunology,pathology T-Lymphocytes, Regulatory/immunology,pathology
Chemicals
RNA, Messenger Interferon-gamma Esterases serine esterase
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Cooper C L
Department of Pathology, University of Southern California, School of Medicine, Los Angeles 90033.
Mueller C
Sinchaisri T A
Pirmez C
Chan J
Kaplan G
Young S M
Weissman I L
Bloom B R
Rea T H
Modlin R L
References (44)
44 references, click to expand
  1. Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon.
    Lancet. 1969 Nov 1;2(7627):933-5 PMID: 4186599
  2. The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2.
    J Exp Med. 1989 Mar 1;169(3):909-19 PMID: 2522499
  3. Renal manifestations of leprosy: glomerulonephritis, a complication of erythema nodosum leprosum.
    Am J Trop Med Hyg. 1973 Jul;22(4):496-502 PMID: 4717692
  4. Mechanism of "reactions" in borderline tuberculoid (BT) leprosy. A preliminary report.
    Acta Pathol Microbiol Scand Suppl. 1973;236(0):45-53 PMID: 4602874
  5. Histological classification and the immunological spectrum of leprosy.
    Bull World Health Organ. 1974;51(5):451-65 PMID: 4549496
  6. Cell mediated and humoral immunity in "reversal reactions".
    Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):267-74 PMID: 776863
  7. Immune complexes and complement hypercatabolism in patients with leprosy.
    Clin Exp Immunol. 1976 Dec;26(3):388-96 PMID: 1009681
  8. Serum and tissue lysozyme in leprosy.
    Infect Immun. 1977 Dec;18(3):847-56 PMID: 591069
  9. Variations in dinitrochlorobenzene responsivity in untreated leprosy: evidence of a beneficial role for anergy.
    Int J Lepr Other Mycobact Dis. 1980 Jun;48(2):120-5 PMID: 7190550
  10. Defect in the generation of cytotoxic T cells in lepromatous leprosy.
    Clin Exp Immunol. 1982 Jun;48(3):633-40 PMID: 6214342
  11. T lymphocyte subsets in the skin lesions of patients with leprosy.
    J Am Acad Dermatol. 1983 Feb;8(2):182-9 PMID: 6219136
  12. T cell subsets in leprosy lesions: in situ characterization using monoclonal antibodies.
    Clin Exp Immunol. 1983 Mar;51(3):421-9 PMID: 6342880
  13. In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis.
    Clin Exp Immunol. 1983 Mar;51(3):430-8 PMID: 6221839
  14. In situ characterization of T lymphocyte subsets in the reactional states of leprosy.
    Clin Exp Immunol. 1983 Jul;53(1):17-24 PMID: 6223731
  15. Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy.
    Clin Exp Immunol. 1984 Mar;55(3):623-8 PMID: 6423326
  16. Immunological unresponsiveness in leprosy.
    Immunol Rev. 1984 Aug;80:5-28 PMID: 6208143
  17. The isolation and characterization of the human suppressor inducer T cell subset.
    J Immunol. 1985 Mar;134(3):1508-15 PMID: 3155770
  18. Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum.
    Arch Dermatol. 1985 Feb;121(2):216-9 PMID: 3156560
  19. The isolation and characterization of the human helper inducer T cell subset.
    J Immunol. 1985 Jun;134(6):3762-9 PMID: 3157750
  20. An in situ immunohistological study of Mitsuda reactions.
    Int J Lepr Other Mycobact Dis. 1985 Sep;53(3):404-9 PMID: 3900247
  21. In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum.
    J Immunol. 1986 Feb 1;136(3):883-6 PMID: 2416837
  22. Monoclonal antibody 9.3 and anti-CD11 antibodies define reciprocal subsets of lymphocytes.
    Eur J Immunol. 1985 Dec;15(12):1164-8 PMID: 3936719
  23. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes.
    Immunology. 1986 Jan;57(1):159-63 PMID: 3002968
  24. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.
    N Engl J Med. 1986 Jul 3;315(1):6-15 PMID: 3086725
  25. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
    Nature. 1986 Jul 31-Aug 6;322(6078):459-61 PMID: 2942780
  26. Suppressor T lymphocytes from lepromatous leprosy skin lesions.
    J Immunol. 1986 Nov 1;137(9):2831-4 PMID: 2944966
  27. Epidermal keratinocyte Ia expression, Langerhans cell hyperplasia and lymphocytic infiltration in skin lesions of leprosy.
    Clin Exp Immunol. 1986 Aug;65(2):253-9 PMID: 2431817
  28. Human T cell subsets.
    Immunol Lett. 1987 Apr;14(4):263-7 PMID: 2953677
  29. CTLA-1 and CTLA-3 serine esterase transcripts are detected mostly in cytotoxic T cells, but not only and not always.
    J Immunol. 1987 Jun 15;138(12):4102-5 PMID: 3495579
  30. Granzyme A secretion by normal activated Lyt-2+ and L3T4+ T cells in response to antigenic stimulation.
    Eur J Immunol. 1987 Aug;17(8):1095-9 PMID: 2957213
  31. Immunoregulatory T lymphocytes in man. Soluble antigen-specific suppressor-inducer T lymphocytes are derived from the CD4+CD45R-p80+ subpopulation.
    J Immunol. 1987 Sep 1;139(5):1501-8 PMID: 2887618
  32. BCG induced CD4+ cytotoxic T cells from BCG vaccinated healthy subjects: relation between cytotoxicity and suppression in vitro.
    Clin Exp Immunol. 1987 Aug;69(2):255-62 PMID: 2958195
  33. The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin.
    J Exp Med. 1987 Oct 1;166(4):1098-108 PMID: 2443597
  34. T-cell receptors of human suppressor cells.
    Nature. 1987 Oct 8-14;329(6139):541-5 PMID: 2958712
  35. Cloning and chromosomal assignment of a human cDNA encoding a T cell- and natural killer cell-specific trypsin-like serine protease.
    Proc Natl Acad Sci U S A. 1988 Feb;85(4):1184-8 PMID: 3257574
  36. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets.
    Immunol Today. 1988 Jul-Aug;9(7-8):195-9 PMID: 2978373
  37. CD8+ T lymphocytes in intracellular microbial infections.
    Immunol Today. 1988 Jun;9(6):168-74 PMID: 3151440
  38. Classification of leprosy according to immunity. A five-group system.
    Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255-73 PMID: 5950347
  39. Learning from lesions: patterns of tissue inflammation in leprosy.
    Proc Natl Acad Sci U S A. 1988 Feb;85(4):1213-7 PMID: 3257577
  40. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells.
    J Immunol. 1988 Apr 1;140(7):2171-8 PMID: 2965180
  41. A high proportion of T lymphocytes that infiltrate H-2-incompatible heart allografts in vivo express genes encoding cytotoxic cell-specific serine proteases, but do not express the MEL-14-defined lymph node homing receptor.
    J Exp Med. 1988 Mar 1;167(3):1124-36 PMID: 3280725
  42. T helper cell cytoplasmic granules. Exocytosis in response to activation via the T cell receptor.
    J Immunol. 1988 Jul 1;141(1):1-9 PMID: 2967863
  43. Efficacy of a cell-mediated reaction to the purified protein derivative of tuberculin in the disposal of Mycobacterium leprae from human skin.
    Proc Natl Acad Sci U S A. 1988 Jul;85(14):5210-4 PMID: 2969108
  44. Mechanisms of reactions in leprosy.
    Int J Lepr Other Mycobact Dis. 1971 Apr-Jun;39(2):417-28 PMID: 4112524
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1989-05-01
Pages
1565-81
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2189323
Subset
IM
Grants
NIAID NIH HHS · AI-22187 · United States
NIAID NIH HHS · AI-22553 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com